Methyl (E)-3-(5-Nitrocyclohex-1-en-1-yl)acrylate: A Key Pharmaceutical Intermediate

Discover the pivotal role of Methyl (E)-3-(5-Nitrocyclohex-1-en-1-yl)acrylate (CAS 900186-90-5) in advancing pharmaceutical synthesis and drug development.

Get a Quote & Sample

Product Advantages

Ensured Efficacy in Pharmaceuticals

The high purity of this pharmaceutical intermediate methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate directly translates to the efficacy and safety of the final active pharmaceutical ingredients it helps create, a crucial factor for any Vorapaxar Sulfate synthesis.

Streamlined Synthesis Processes

Leveraging this compound as a methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate manufacturer China's offering can simplify complex synthesis routes, saving time and resources in drug development.

Critical for Cardiovascular Health

Its role as an intermediate for cardiovascular drugs highlights its contribution to healthcare advancements, making it a vital CAS 900186-90-5 intermediate for research and production.

Key Applications

API Intermediate

Crucial for the synthesis of Active Pharmaceutical Ingredients (APIs), ensuring the quality required when you buy methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate for drug manufacturing.

Drug Discovery & Development

Serves as a key building block in the research and development phase of new pharmaceutical compounds, supporting innovation in drug design.

Cardiovascular Medication Synthesis

Essential intermediate for drugs like Vorapaxar Sulfate, directly impacting treatments for cardiovascular conditions and making it a key chemical intermediate 900186-90-5.

Complex Organic Synthesis

Its versatile structure makes it valuable for various complex organic synthesis pathways beyond immediate pharmaceutical applications.